Related references
Note: Only part of the references are listed.Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors
Kah-Lok Chan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Inhye E. Ahn et al.
BLOOD (2017)
Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations
Adam R. Johnson et al.
ACS CHEMICAL BIOLOGY (2016)
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A. Burger et al.
NATURE COMMUNICATIONS (2016)
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu et al.
BLOOD (2015)
Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110 delta result in T cell senescence and human immunodeficiency
Carrie L. Lucas et al.
NATURE IMMUNOLOGY (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dysfunction of phospholipase Cγ in immune disorders and cancer
Hans Koss et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Structural and Functional Integration of the PLCγ Interaction Domains Critical for Regulatory Mechanisms and Signaling Deregulation
Tom D. Bunney et al.
STRUCTURE (2012)
Electrostatic control of the membrane targeting of C2 domains
D Murray et al.
MOLECULAR CELL (2002)
EF-hand calcium-binding proteins
A Lewit-Bentley et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2000)
Share Paper
